-
Study aim
-
Evaluation of the effectiveness of the enhanced Brain Pert device on visual field observation, detection of black and white color contrast and sharpness of the visually impaired and blind
-
Design
-
Clinical trial with control group, with parallel groups, not blinded, on 30 patients
-
Settings and conduct
-
Patients who will come for eye examination will be referred to Heshmatieh Sabzevar Hospital, and then a list of visually impaired people who were between 20 and 50 years of age and who referred to Sabzevar Hospital in 2022 will be prepared. The criteria for diagnosing low vision will be an ophthalmologist. Their numbers will be contacted
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria:
Failure to receive psychological treatment
Patient consent to participate in the study
- Lack of vision in a person is congenital
Exclusion criteria:
Oral lesions or cleft palate
Structural and neurological disorders of the tongue
-smoking
-MR (mental retardation)
The dissatisfaction of the person continuing the research
-
Intervention groups
-
There will be two groups (15 controls) and (15 experiments). Patients were introduced to the features of the BrainPort vision device, including turning the device on and off, field of view / zoom features, light intensity control, and inversion controls. We also showed maintenance issues such as how to replace the battery, how to take care of the device and troubleshooting solutions. The limitations of this technology were discussed, such as lack of color, lack of 3D depth perception, and that the stimulus is primarily a tactile perception. At the end of the sessions, due to ethical issues, 5 sessions of treatment will be performed on the control group.
The next session of the informed consent form and pre-test will be performed.
-
Main outcome variables
-
Field of vision, black and white color contrast detection